학술논문

MRI‐assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction
Document Type
article
Source
Alzheimer's & Dementia. 17(6)
Subject
Biological Psychology
Psychology
Basic Behavioral and Social Science
Neurodegenerative
Sleep Research
Alzheimer's Disease
Neurosciences
Prevention
Brain Disorders
Behavioral and Social Science
Aging
Acquired Cognitive Impairment
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Dementia
Aetiology
2.1 Biological and endogenous factors
Aged
Cognition
Cognitive Dysfunction
Disease Progression
Humans
Locus Coeruleus
Magnetic Resonance Imaging
Male
Memory Disorders
Neuropsychological Tests
Sleep
Alzheimer's disease
heritability
locus coeruleus
mild cognitive impairment
neuromelanin magnetic resonance imaging
sleep-wake disturbance
Clinical Sciences
Geriatrics
Clinical sciences
Biological psychology
Language
Abstract
IntroductionThe locus coeruleus (LC) undergoes extensive neurodegeneration in early Alzheimer's disease (AD). The LC is implicated in regulating the sleep-wake cycle, modulating cognitive function, and AD progression.MethodsParticipants were 481 men (ages 62 to 71.7) from the Vietnam Era Twin Study of Aging. LC structural integrity was indexed by neuromelanin-sensitive magnetic resonance imaging (MRI) contrast-to-noise ratio (LCCNR ). We examined LCCNR , cognition, amnestic mild cognitive impairment (aMCI), and daytime dysfunction.ResultsHeritability of LCCNR was .48. Participants with aMCI showed greater daytime dysfunction. Lower LCCNR was associated with poorer episodic memory, general verbal fluency, semantic fluency, and processing speed, as well as increased odds of aMCI and greater daytime dysfunction.DiscussionReduced LC integrity is associated with widespread differences across cognitive domains, daytime sleep-related dysfunction, and risk for aMCI. These findings in late-middle-aged adults highlight the potential of MRI-based measures of LC integrity in early identification of AD risk.